Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Cunto peso puedo perder con GLP-1
Appetite suppression = fewer dopamine spikes from food
The study followed 592 adults, divided into two groups (or cohorts): The participants Cohort A: 465 people living with obesity but no type 2 diabetes Cohort B: 127 patients who had both obesity and type 2 diabetes Weight loss results For people without diabetes: 12.3% to 16.2% average weight loss when counting everyone who started Up to 19.9% for people who completed the full study The placebo group lost only 2.5% For people with obesity and diabetes: 8.4% to 12.3% weight loss overall Up to 17% for those who finished treatment The placebo group lost just 1.7% What do these numbers mean
Clinical data on visceral fat reduction (tesamorelin) was measured at 26 weeks
US$ 25.68
US$ 23.40
US$ 26.94
US$ 28.03
